Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 5/20 | 0.54 |
| ▸ | NPY2R | P49146 | 7/20 | 0.51 |
| ▸ | NPY4R | P50391 | 7/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.51 |
| ▸ | NPY1R | P25929 | 5/20 | 0.51 |
| ▸ | TFPI | P10646 | 4/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.50 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31467766 | 0.95 | NPY2R (0.54) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31467768 | 0.91 | CXCR4 (0.55) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31467763 | 0.90 | EPHA2 (0.48) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31467773 | 0.90 | RAMP3 (0.51) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30175378 | 0.89 | RAMP3 (0.56) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31467754 | 0.88 | KDM1A (0.59) | CXCR4NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30562225 | 0.87 | NPY2R (0.56) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL31437189 | 0.87 | MAPK8 (0.54) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL31437179 | 0.87 | TFPI (0.56) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL31437214 | 0.87 | NPY2R (0.56) | NPY2RNPY4RNPY5RNPY1RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |